Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-002474
Filing Date
2019-01-23
Accepted
2019-01-23 17:28:09
Documents
1
Group Members
FORESITE CAPITAL FUND IV, L.P.FORESITE CAPITAL MANAGEMENT III, LLCFORESITE CAPITAL MANAGEMENT IV, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G tv511465_sc13g.htm SC 13G 95738
  Complete submission text file 0001144204-19-002474.txt   97417
Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund III, L.P. (Filed by) CIK: 0001645158 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Subject) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-90574 | Film No.: 19538162
SIC: 2836 Biological Products, (No Diagnostic Substances)